Unlike CD4+ T cells, which operate under MHC-II restriction, CD8+ T cells can activate CD40 on virtually any cell, including cancer cells, upon recognizing specific peptide/MHC-I complexes with their T cell receptor (TCR). The gene discussed is CD8A; the disease is cancer.